These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6687966

  • 1. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
    Abdyldaev RA, Kruglova GV.
    Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966
    [Abstract] [Full Text] [Related]

  • 2. Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
    Sonneveld P, Hop W, Mulder AH, Michiels JJ, Blijham G, van de Lelie J, Raemakers JW, Nieuwenhuis K, van der Heul C.
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):9-12. PubMed ID: 8073309
    [No Abstract] [Full Text] [Related]

  • 3. Cyclophosphamide, epirubicin, vincristine, and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
    Comella P, Abate G, Fiore M, Di Finizio G, Zarrilli D.
    J Chemother; 1989 Jul; 1(4 Suppl):1257-8. PubMed ID: 16312856
    [No Abstract] [Full Text] [Related]

  • 4. [Polychemotherapy of lymphosarcoma by the COP program].
    Abdullaev RA, Poddubnaia IV, Shramko AF.
    Sov Med; 1984 Jul; (7):103-6. PubMed ID: 6385297
    [No Abstract] [Full Text] [Related]

  • 5. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
    Blayney DW, McGuire BW, Cruickshank SE, Johnson DH.
    Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Therapy against relapse in generalized lymphoblastic and immunoblastic lymphosarcomas in complete remission].
    Mustiatsé LZ, Korchmaru IF.
    Ter Arkh; 1986 Feb; 58(6):110-2. PubMed ID: 3764703
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [A comparative trial of C-novantrone OP(CNOP) vs C-adriamycin OP(CHOP) in the treatment of stage II-IV malignant lymphoma--the preliminary report].
    Chuang MW, Tzeng CH, Chiou TJ, Chiu CF, Hsieh RK, Liu JH, Chen PM.
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Jan; 41(1):51-6. PubMed ID: 3167650
    [No Abstract] [Full Text] [Related]

  • 10. Stage I and II non-Hodgkin's lymphoma: results of combined of THP-COP chemotherapy and radiotherapy.
    Ohga S, Nakamura K, Shioyama Y, Sasaki T, Urashima Y, Terashima H, Honda H.
    Radiat Med; 2005 May; 23(3):156-61. PubMed ID: 15940061
    [Abstract] [Full Text] [Related]

  • 11. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T, Tsuchiya K, Nishioka S, Kitahara T, Ohmori K, Homma A, Aoyma H, Shindoh M, Shirato H.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):847-52. PubMed ID: 15465202
    [Abstract] [Full Text] [Related]

  • 12. [Possibilities of using polychemotherapy according to the COP protocol in lymphosarcoma of the gastrointestinal tract].
    Poddubnaia IV.
    Ter Arkh; 1985 Nov 01; 57(2):103-6. PubMed ID: 3890247
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma].
    Rolski J, Koralewski P, Pawlicki M.
    Wiad Lek; 1993 May 01; 46(9-10):356-9. PubMed ID: 8236992
    [Abstract] [Full Text] [Related]

  • 15. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Mounier N, Gisselbrecht C, Lepage E.
    N Engl J Med; 1998 Nov 12; 339(20):1476; author reply 1477. PubMed ID: 9841320
    [No Abstract] [Full Text] [Related]

  • 16. New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only--a preliminary update of the German Low-Grade Lymphoma Study Group.
    Hiddemann W, Unterhalt M, Koch P, Nahler M, Herrmann R.
    Semin Hematol; 1994 Apr 12; 31(2 Suppl 3):32-5. PubMed ID: 8073307
    [No Abstract] [Full Text] [Related]

  • 17. Deferral of initial therapy for advanced indolent lymphomas.
    Portlock CS.
    Cancer Treat Rep; 1982 Mar 12; 66(3):417-9. PubMed ID: 7037178
    [No Abstract] [Full Text] [Related]

  • 18. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone.
    Bagley CM, Devita VT, Berard CW, Canellos GP.
    Ann Intern Med; 1972 Feb 12; 76(2):227-34. PubMed ID: 5066691
    [No Abstract] [Full Text] [Related]

  • 19. [Gastrointestinal lymphomas: results of multimodal therapy in 57 patients of one center].
    Kiene J, Sezer O, Rasche H, Klempa I.
    Langenbecks Arch Chir Suppl Kongressbd; 1996 Feb 12; 113():244-6. PubMed ID: 9101844
    [Abstract] [Full Text] [Related]

  • 20. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.